Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

Back

Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial

Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial
Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial

Medication-overuse headache (MOH) is common in the general population. We investigated effectiveness of brief intervention (BI) for achieving drug withdrawal in primary care patients with MOH.

See All

Key take away

In this research paper, gain from effective management of MOH in primary care, thus benefiting patients and society and reduction in economic costs has been mentioned. General practitioners experience brief intervention as a practical approach towards MOH.

Background

Medication-overuse headache (MOH) is common in the general population. We investigated effectiveness of brief intervention (BI) for achieving drug withdrawal in primary care patients with MOH.

Method

The study was double-blind, pragmatic and cluster-randomised controlled. A total of 25 486 patients (age 18–50) from 50 general practitioners (GPs) were screened for MOH. GPs defined clusters and were randomised to receive BI training (23 GPs) or to continue business as usual (BAU; 27 GPs). The Severity of Dependence Scale was applied as a part of the BI. BI involved feedback about individual risk of MOH and how to reduce overuse. Primary outcome measures were reduction in medication and headache days/month 3 months after the intervention and were assessed by a blinded clinical investigator.

Result

42% responded to the postal screening questionnaire, and 2.4% screened positive for MOH. A random selection of up to three patients with MOH from each GP were invited (104 patients), 75 patients were randomised and 60 patients included into the study. BI was significantly better than BAU for the primary outcomes (p<0.001). Headache and medication days were reduced by 7.3 and 7.9 (95% CI 3.2 to 11.3 and 3.2 to 12.5) days/month in the BI compared with the BAU group. Chronic headache resolved in 50% of the BI and 6% of the BAU group.

Conclusion

The BI method provides GPs with a simple and effective instrument that reduces medication-overuse and headache frequency in patients with MOH.

Source:

J Neurol Neurosurg Psychiatry. 2015 May; 86(5): 505–512.

Article:

Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomized parallel controlled trial

Authors:

Espen Saxhaug Kristoffersen et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: